Reduced expression of EphB2 that parallels invasion and metastasis in colorectal tumours. - Test2 - elhamkhani - TriplyDB

Reduced expression of EphB2 that parallels invasion and metastasis in colorectal tumours.

Reduced expression of EphB2 that parallels invasion and metastasis in colorectal tumours.

http://www.wikidata.org/entity/Q46792289

about

SHARPIN is an endogenous inhibitor of β1-integrin activation Three-dimensional Structure of the EphB2 Receptor in Complex with an Antagonistic Peptide Reveals a Novel Mode of Inhibition EPHB2 germline variants in patients with colorectal cancer or hyperplastic polyposis.The radiosensitizing effect of doranidazole on human colorectal cancer cells exposed to high doses of irradiation.High expression of erythropoietin-producing hepatoma cell line-B2 (EphB2) predicts the efficiency of the Qingyihuaji formula treatment in pancreatic cancer CFPAC-1 cells through the EphrinB1-EphB2 pathway.The differential expression of EphB2 and EphB4 receptor kinases in normal bladder and in transitional cell carcinoma of the bladder Eph receptor tyrosine kinases in cancer stem cells Identification of alterations in DNA copy number in host stromal cells during tumor progression Eph receptors and ephrins as targets for cancer therapy.Molecular mechanisms of cell segregation and boundary formation in development and tumorigenesis.Clinical relevance of Ephs and ephrins in cancer: lessons from breast, colorectal, and lung cancer profiling.Phosphorylation of ephrin-B1 regulates dissemination of gastric scirrhous carcinoma EphB2 activity plays a pivotal role in pediatric medulloblastoma cell adhesion and invasion The EphA2 receptor and ephrinA1 ligand in solid tumors: function and therapeutic targeting.Epigenetic silencing of EphA1 expression in colorectal cancer is correlated with poor survival.Dissociation of EphB2 signaling pathways mediating progenitor cell proliferation and tumor suppression.Epigenetic silencing of the human NOS2 gene: rethinking the role of nitric oxide in human macrophage inflammatory responses.Paradoxes of the EphB1 receptor in malignant brain tumors.EPH-EPHRIN in human gastrointestinal cancers The Eph/Ephrin family in cancer metastasis: communication at the service of invasion.Regulation and misregulation of Eph/ephrin expression.Eph and ephrins in epithelial stem cell niches and cancer.Cancer-associated fibroblasts drive the progression of metastasis through both paracrine and mechanical pressure on cancer tissue.Eph- and ephrin-dependent mechanisms in tumor and stem cell dynamics.EphrinB3 is an anti-apoptotic ligand that inhibits the dependence receptor functions of EphA4 receptors during adult neurogenesis.Activation of EphA4 and EphB2 Reverse Signaling Restores the Age-Associated Reduction of Self-Renewal, Migration, and Actin Turnover in Human Tendon Stem/Progenitor Cells.A review on Eph/ephrin, angiogenesis and lymphangiogenesis in gastric, colorectal and pancreatic cancers A support vector machine classifier for the prediction of osteosarcoma metastasis with high accuracy.Gene expression profiling in familial adenomatous polyposis adenomas and desmoid disease.Transcriptional profiling identifies genes induced by hepatocyte-derived extracellular matrix in metastatic human colorectal cancer cell lines.Over-expression of EphB3 enhances cell-cell contacts and suppresses tumor growth in HT-29 human colon cancer cells.In situ validation of an intestinal stem cell signature in colorectal cancer.Dysregulation of EGFR Pathway in EphA2 Cell Subpopulation Significantly Associates with Poor Prognosis in Colorectal Cancer.Loss of EphB6 protein expression in human colorectal cancer correlates with poor prognosis.An EphB-Abl signaling pathway is associated with intestinal tumor initiation and growth.Biomarkers for the identification of precursor polyps of colorectal serrated adenocarcinomas.Alterations in the thymocyte phenotype of EphB-deficient mice largely affect the double negative cell compartment.Increased EphB2 expression predicts cholangiocarcinoma metastasis.Influence of A9 region mutation in EphB2 gene in the prognosis of patients with colorectal adenocarcinoma.Differential Expression Patterns of Eph Receptors and Ephrin Ligands in Human Cancers.

P2860

Q24338618-0F41A40A-B935-4F4D-86B7-FC9BED1D6A2E Q27648574-3D86D015-E3D2-4C08-9E7D-07E319951235 Q33245402-F4B8841E-DCF8-4ECE-9178-D62F38C50AA7 Q33301766-FF26E97A-DC8C-448E-8C9C-B267E9B2E707 Q33778296-5C637219-2F0C-4464-BA3A-DC35A7C8B17A Q34078717-1EC1A8BC-9580-4359-AA64-B5B4BAD1F722 Q34527304-A715A401-8037-4A79-A3C5-91F478947C9E Q35222185-64E67ED3-A4B7-4708-89E8-B4D66A96B8FB Q35370195-51C0059C-2E80-4B4E-BC03-BF1DA476F6CE Q35645904-BCCAD26F-9C12-4DA6-9C7E-3C56044053FD Q35783568-2087D4C5-E6DC-46AB-BD35-7405482334F4 Q35928209-E5FBA7B5-729B-45B5-AB0A-E1670DEEAA8A Q36179161-17F8BDE8-DD26-4A4C-B059-4E1848FA7915 Q36950556-38083F1C-E4D9-467C-9F84-DD5079480190 Q37160698-985CB699-9BB4-4A9F-8131-1036A3B39081 Q37450404-920983A4-AD90-4320-822F-CB84C8A686BE Q37620142-03798369-BCAD-4C90-98AA-8D0D72EB3047 Q37633690-C5B2D694-0715-4CB6-BE85-3C35CEF68E3B Q37824603-85CE5472-C73F-4B78-9184-BE066CE00D67 Q38006838-B07D7CD8-DE74-464C-8141-AF6182E2FDD1 Q38008491-4DA9CEB6-840C-4FAD-8A50-05A5CBC5F37C Q38008492-6D719080-DF87-4BDA-AC29-64E5BE42015A Q38048249-75F8B0AB-7F01-475C-A284-F1B9FC094F6E Q38209232-96BA36A6-9D3F-4D76-B2E4-11F9ED9E3255 Q39926049-AFA1086A-F5D7-47BF-B42A-932E691DB1F9 Q40095672-58682DEF-FDC7-499B-9B0D-6776CCC43D85 Q41662329-277C89CA-B075-421A-BC65-450DB8017BCB Q42280200-5A833002-D1F4-4D53-89CE-A7AE0B75EFB9 Q42544255-77173390-057B-4F04-A6CD-7286BA647CB5 Q45204638-FD2223A7-5483-4512-8E22-25426886DAB9 Q45989150-4822ABD3-5536-401A-8A57-AA3213F45392 Q46080136-CB7FC94B-8E27-454E-8BB8-0935D4646A4E Q50232638-6D3F66BF-90FB-4827-976F-BEA3C3EB8D63 Q50454825-B5AFD7AD-73E2-4AFE-A7DC-D015F23439E8 Q50593562-6F0F8C36-586D-4E27-B01D-5DE526B69042 Q53187965-F249A465-66DF-43A2-BF6A-66EC7E5060A0 Q53485869-075DA3DA-FE43-46AE-92B2-78198C196706 Q54338851-42A3E4C6-802E-4C56-9D38-352270E0502C Q54626344-C7ED473D-2FBB-49F2-A141-B4FA0CCF65E7 Q55286883-CB6EF7E7-696D-4951-A3B0-1193D8246B00

P2860

Reduced expression of EphB2 that parallels invasion and metastasis in colorectal tumours.

http://www.wikidata.org/entity/Q46792289

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh-hant

name

Reduced expression of EphB2 that parallels invasion and metastasis in colorectal tumours.

@en

Reduced expression of EphB2 that parallels invasion and metastasis in colorectal tumours.

@nl

type

label

Reduced expression of EphB2 that parallels invasion and metastasis in colorectal tumours.

@en

Reduced expression of EphB2 that parallels invasion and metastasis in colorectal tumours.

@nl

prefLabel

Reduced expression of EphB2 that parallels invasion and metastasis in colorectal tumours.

@en

Reduced expression of EphB2 that parallels invasion and metastasis in colorectal tumours.

@nl

P1433

Q46792289-266060FB-D557-48C2-8E1E-CCF53DCD2935

P1476

Q46792289-3FC3EBC6-7B06-4896-8719-C255FCAA32FC

P2093

Q46792289-0F97BABB-CB20-43CA-B902-78EDD907FC6B

Q46792289-221390B1-9A9E-4D25-8558-2B6518757847

Q46792289-6E331BBA-B19B-42D5-8CBD-1EB67DCB97CD

Q46792289-9C9C135E-5C50-4820-8FA6-8A9A84962C7F

Q46792289-9D998443-9B2A-4F7F-90B9-218C6F46D777

Q46792289-CF6ED4CC-3B36-46B3-B6DA-E287C6813FE3

Q46792289-DA47A90F-AED2-4038-8E2F-0668E4485317

Q46792289-F6642C43-7F39-40B9-808C-3FB1F13FB89D

P2860

Q46792289-01AB3124-4F76-4CCD-BBD2-BC67954E6682

Q46792289-0E6415C5-0851-4761-B242-21D580A64017

Q46792289-1A441E13-9E5A-483C-BB57-BC78599BFC27

Q46792289-1EE19084-67BC-494F-816A-802F6F9B2571

Q46792289-289045C6-B435-4379-BC87-9E194EAE89BD

Q46792289-385276E7-D7F2-4D4D-AA07-605CCF8FE138

Q46792289-49C3F637-FBFE-4033-9D3C-59D83F526CAA

Q46792289-540FAF07-251D-4F06-957E-C780E5ED2807

Q46792289-55E691A2-0961-4EED-B683-86CCC51A8961

Q46792289-66C1D7F8-1E2A-40C8-96AF-84175D471165

P304

Q46792289-ECE87E75-8BC2-47C1-8806-CE4400866EE6

P31

Q46792289-17934C9F-4A9E-4F06-98B7-8D0F5749AF65

P356

Q46792289-EB3F4FCA-8452-4502-8F33-6E9B7BC8573B

P407

Q46792289-640BBAD5-F953-418F-ACA3-96EB71F833B0

P433

Q46792289-7E844231-86AC-45E6-9C59-BF9E511EA3C4

P478

Q46792289-B1DC115C-112D-4C83-BA7B-9F18893211A2

P50

Q46792289-A84D9383-8581-4571-AED3-75A036211ABC

P577

Q46792289-ADE842F9-984B-4E1C-B784-EB81C3B07697

P5875

Q46792289-2E276FC1-9893-42D0-9ACF-EDF8BEA150C7

P698

Q46792289-77CE3A29-7DAE-4067-A9BA-CCBD155FE3BF

P356

P1433

P1476

Reduced expression of EphB2 that parallels invasion and metastasis in colorectal tumours.

@en

P2093

Annie S Y Chan

http://www.w3.org/2001/XMLSchema#string

Coral Ho

http://www.w3.org/2001/XMLSchema#string

Dong Li Guo

http://www.w3.org/2001/XMLSchema#string

Ji Zhang

http://www.w3.org/2001/XMLSchema#string

Siu Tsan Yuen

http://www.w3.org/2001/XMLSchema#string

Suet Yi Leung

http://www.w3.org/2001/XMLSchema#string

Wai Yin Tsui

http://www.w3.org/2001/XMLSchema#string

Xin Chen

http://www.w3.org/2001/XMLSchema#string

P2860

Inhibition of integrin-mediated cell adhesion but not directional cell migration requires catalytic activity of EphB3 receptor tyrosine kinase. Role of Rho family small GTPases

The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells

Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC

Epithelial-mesenchymal transitions in tumour progression

Coexpression of ephrin-Bs and their receptors in colon carcinoma

Multiple signaling interactions of Abl and Arg kinases with the EphB2 receptor

APC mutations occur early during colorectal tumorigenesis

Identification of protein-tyrosine kinase genes preferentially expressed in embryo stomach and gastric cancer

Beta-catenin and TCF mediate cell positioning in the intestinal epithelium by controlling the expression of EphB/ephrinB

Loss of Apc in vivo immediately perturbs Wnt signaling, differentiation, and migration

P304

454-464

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/CARCIN/BGI259

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

27

http://www.w3.org/2001/XMLSchema#string

P50

P577

2005-11-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7496275

http://www.w3.org/2001/XMLSchema#string

P698

16272170

http://www.w3.org/2001/XMLSchema#string